NCT00005783View on ClinicalTrials.gov

A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2000

Study Completion Date

October 31, 2000

Conditions

Hemoglobin SC DiseaseSickle Cell Anemia

Interventions

DRUG

Recombinant-methionyl human stem cell factor

Trial Locations (1)

20892

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda

All Listed Sponsors

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00005783 - A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders | Biotech Hunter | Biotech Hunter